Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility Jan 18, 2022
Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health… Jan 18, 2022
Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted… Jan 13, 2022
How Significant Are Recent Changes To Psychedelics Access In Canada? ‘It Can’t Be Understated’ Says Numinus CEO Jan 12, 2022
Field Trip Reveals Plans to Help Patients Access Psilocybin and MDMA Through Health Canada Jan 6, 2022
Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program… Jan 6, 2022